Journey Colab
Ron has over 30 years’ experience as a clinical pharmacologist/toxicologist in the pharmaceutical and biotech industry. He has written the pharmacology/toxicology and clinical pharmacology sections for global regulatory submissions, including pre-IND packages, IND/CTA, BLA/NDA/MAA packages as well as investigator brochures and annual reports. Prior to consulting, he was in leadership roles at Arena, Takeda, J&J, Schering-Plough, Ligand, and Bayer.
This person is not in any offices
Journey Colab
Journey Colab is pursuing FDA approval of psychedelic therapies to heal individual mental health and strengthen communities. They plan to build a portfolio of plant-identical compounds. Their first compound in development is mescaline.